• Præsentation
• CV
• Aktiviteter

The research proposal highlights the issue of excessive prices in the field of pharmaceuticals, an issue that has been in the forefront of fierce academic and political debate for many years, following the enactment of the TRIPS Agreement and the subsequent Doha Ministerial Declaration on the TRIPS Agreement and Public Health.

The thesis conducts an investigation of the triangular dilemma of strong Intellectual Property protection, contra excessive prices of medicines as result of the global Intellectual Property regime and finally the legal-economic rationales and discourses underlying Intellectual Property Law / competition law / determination of when a price is excessive and how.

The aim is to establish what constitutes anti-competitive practices such as excessive prices in TRIPS & EU Competition Law, by developing the discourse on assessement of excessive prices as an anti-competitive practice in and out of themselves from a legal-economic / competition law perspective.

Undervisnings- og vejledningsområder

Behrang Kianzad teaches master-level courses in EU Intellectual Property Law as well as EU Competition Law at the Faculty of Law, Copenhagen University.